The new Medicare drug-prescription program debuted this week to praise and to criticism. The government touts deep discounts for seniors. Skeptics site a cumbersome process not always worth the payoff. Join NPR's Neal Conan and his guests for a guide to Medicare's new prescription drug program.
Dr. Mark McClellan
*Administrator of the Centers for Medicare and Medicaid Services
*NPR's health policy correspondent
*Director of Health Programs, American Institutes for Research, a public policy research organization in Silver Spring, Md.